USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 144 filers reported holding USANA HEALTH SCIENCES INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,250,038 | +29.5% | 38,390 | +39.3% | 0.00% | +50.0% |
Q2 2023 | $1,737,887 | -7.2% | 27,568 | -7.4% | 0.00% | -33.3% |
Q1 2023 | $1,873,351 | +56.5% | 29,783 | +32.3% | 0.00% | +50.0% |
Q4 2022 | $1,197,213 | -99.9% | 22,504 | -23.8% | 0.00% | -33.3% |
Q3 2022 | $1,656,334,000 | +7.6% | 29,551 | +38.9% | 0.00% | +50.0% |
Q2 2022 | $1,539,893,000 | -20.6% | 21,281 | -12.8% | 0.00% | -33.3% |
Q1 2022 | $1,938,580,000 | -19.7% | 24,400 | +2.3% | 0.00% | 0.0% |
Q4 2021 | $2,413,721,000 | -8.9% | 23,851 | -17.0% | 0.00% | -25.0% |
Q3 2021 | $2,649,644,000 | +66.5% | 28,738 | +85.0% | 0.00% | +100.0% |
Q2 2021 | $1,590,943,000 | +214.0% | 15,532 | +199.2% | 0.00% | +100.0% |
Q1 2021 | $506,642,000 | +59.0% | 5,191 | +25.6% | 0.00% | 0.0% |
Q4 2020 | $318,654,000 | +4.0% | 4,133 | -0.7% | 0.00% | – |
Q3 2020 | $306,531,000 | +108.8% | 4,162 | +108.2% | 0.00% | – |
Q2 2020 | $146,787,000 | -83.6% | 1,999 | -87.1% | 0.00% | -100.0% |
Q1 2020 | $897,302,000 | +199.1% | 15,535 | +306.8% | 0.00% | +100.0% |
Q4 2019 | $299,982,000 | +91.0% | 3,819 | +66.3% | 0.00% | – |
Q3 2019 | $157,092,000 | -17.1% | 2,297 | -3.7% | 0.00% | – |
Q2 2019 | $189,441,000 | -29.5% | 2,385 | -25.6% | 0.00% | -100.0% |
Q1 2019 | $268,719,000 | +124.9% | 3,204 | +215.7% | 0.00% | – |
Q4 2018 | $119,496,000 | +35.4% | 1,015 | +38.7% | 0.00% | – |
Q3 2018 | $88,243,000 | -31.7% | 732 | -34.6% | 0.00% | – |
Q2 2018 | $129,136,000 | -42.6% | 1,120 | -57.2% | 0.00% | – |
Q1 2018 | $224,800,000 | -90.9% | 2,617 | -92.2% | 0.00% | -100.0% |
Q4 2017 | $2,474,973,000 | +2345.5% | 33,423 | +1805.5% | 0.00% | – |
Q3 2017 | $101,206,000 | -25.2% | 1,754 | -16.9% | 0.00% | – |
Q2 2017 | $135,315,000 | +25.9% | 2,111 | +13.1% | 0.00% | – |
Q1 2017 | $107,482,000 | -26.3% | 1,866 | -21.7% | 0.00% | -100.0% |
Q4 2016 | $145,840,000 | +55.2% | 2,383 | +251.0% | 0.00% | – |
Q3 2016 | $93,940,000 | +79.8% | 679 | +44.8% | 0.00% | – |
Q2 2016 | $52,261,000 | +221.2% | 469 | +250.0% | 0.00% | – |
Q1 2016 | $16,270,000 | -92.3% | 134 | -91.9% | 0.00% | -100.0% |
Q4 2015 | $211,044,000 | -1.2% | 1,652 | +3.6% | 0.00% | 0.0% |
Q3 2015 | $213,644,000 | +90.4% | 1,594 | +94.2% | 0.00% | – |
Q2 2015 | $112,198,000 | +616.1% | 821 | +482.3% | 0.00% | – |
Q1 2015 | $15,668,000 | -96.6% | 141 | -96.9% | 0.00% | -100.0% |
Q4 2014 | $463,809,000 | +18.6% | 4,521 | -14.8% | 0.00% | – |
Q3 2014 | $390,987,000 | +8.6% | 5,308 | +15.2% | 0.00% | – |
Q2 2014 | $360,069,000 | +19.8% | 4,608 | +4.0% | 0.00% | – |
Q1 2014 | $300,620,000 | – | 4,430 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 34,732 | $3,563,000 | 3.33% |
Matarin Capital Management, LLC | 28,322 | $2,905,554,000 | 1.28% |
Capital Impact Advisors, LLC | 21,373 | $2,193,000 | 1.03% |
USA FINANCIAL FORMULAS | 20,088 | $2,061,000 | 0.71% |
Camarda Financial Advisors, LLC | 8,951 | $918,000 | 0.58% |
Invictus RG Pte. Ltd. | 4,862 | $499,000 | 0.54% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 78,238 | $8,026,000 | 0.53% |
Wolf Group Capital Advisors | 6,696 | $687,000 | 0.50% |
RQSI Ltd | 3,937 | $404,000 | 0.38% |
CLARK ESTATES INC/NY | 23,759 | $2,437,000 | 0.36% |